Acta Scientific Pharmacology

Editorial Volume 3 Issue 4

Oral Bioavailability: A Key Concept in Drug Delivery

Goverdhan Lanka*

Research Associate, Epigenetic Research Laboratory, Department of Pharmacy, BITS-Pilani Hyderabad Campus, Telangana, India

*Corresponding Author: Goverdhan Lanka, Research Associate, Epigenetic Research Laboratory, Department of Pharmacy, BITS-Pilani Hyderabad Campus, Telangana, India.

Received: January 27, 2022; Published: March 01, 2022

  Oral drug absorption and bioavailability are important parameters in pharmacology to consider in drug designing for producing therapeutic efficacy for desired pharmacological effect. There are multiple ways of drug administration established for the existing drug where the intravenous method of administration has 100% bioavailability. The most convenient method of administration for most of the clinically approved drugs is an oral route where most of the drugs face challenges with poor pharmacokinetic properties including their bioavailability [1]. The more bioavailability of a molecule makes it a promising and ideal drug-like compound in intervening pathogenesis. As per the European Medical Agency (EMA), oral drug bioavailability is defined as “The rate and extent to which an active moiety is absorbed from a pharmaceutical form and becomes available in the systematic circulation” [2]. Designing drugs with high bioavailability is a challenging task for drug discovery scientists as they still trying to overcome the absorption and bioavailability issues with new strategies. Having poor bioavailability or absorption of the drug compromises the chances of developing a successful drug. The correction of the loopholes should enhance the rate of efficiency might be through smart drug delivery systems. Enhancement of oral bioavailability reduces the dose of the drug and the risk of side effects associated with the drug. Overall, the early prediction of the oral bioavailability of drug molecules may enhance the success rate in drug discovery. Molecular properties of drug candidates such as physicochemical influence the oral absorption and bioavailability of a drug. Bioavailability highly depends on physicochemical parameters like molecular structural features, molecular weight, solubility, first-pass effect, and permeability. Increasing the dosage of drugs, changing the pharmaceutical formulation, and changing in route of drug administration are the conventional methods to increase oral bioavailability. Biochemical and metabolic processes such as intestinal metabolism by digestive enzymes, and first-pass metabolism may limit the bioavailability of drugs. All these disadvantages may be overcome by enhancing the physicochemical and biochemical properties of drug candidates. Experimental prediction of human oral bioavailability emerged as an expensive and laborious measurement to carry out [3,4]. The conventional strategy like changing the pharmaceutical formulation of drugs can alter the oral absorption and bioavailability of drugs. Prodrug strategy can help to improve the absorption and bioavailability of a drug by triggering the drug metabolism and first-pass effect. The good cellular permeability of drugs can be achieved by working with their lipophilicity and polarity while designing the drug molecules. The addition of suitable surfactants to the drug may enhance the bioavailability by improving its solubility and permeability during drug formulations. Absorption enhancers, salt formation, and drug complexion techniques may also increase the bioavailability of the drug. Apart from employing the conventional methods to identify the drug bioavailability, one of the effective approaches to enhance drug-like properties and check its oral bioavailability is by developing in silico models using existing bioactive molecules by predicting its pharmacokinetic properties before drug development using QSAR, QSPR methods. This can be done by calculating molecular descriptors for designing new drug candidates which may improve the success rate of drug development with maximum human oral absorption and bioavailability during clinical studies [2,4,5]. As a future perspective, we need to understand the drug development process by keenly looking at their physicochemical, biological properties, drug-drug interactions, metabolism to develop advanced methods to improve the bioavailability of drug candidates as part of a successful drug discovery process.


Citation: Goverdhan Lanka. “Oral Bioavailability: A Key Concept in Drug Delivery". Acta Scientific Pharmacology 3.4 (2022): 01-02.


Copyright: © 2022 Goverdhan Lanka. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate36%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US